Yoshikazu Murawaki

Author PubWeight™ 86.75‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C. Nat Genet 2009 14.16
2 FibroIndex, a practical index for predicting significant fibrosis in patients with chronic hepatitis C. Hepatology 2007 2.24
3 Preventive and therapeutic effects of angiotensin II type 1 receptor blocker on hepatic fibrosis induced by bile duct ligation in rats. J Gastroenterol 2006 1.53
4 Genome-wide association study confirming association of HLA-DP with protection against chronic hepatitis B and viral clearance in Japanese and Korean. PLoS One 2012 1.44
5 Influence of genotypes and precore mutations on fulminant or chronic outcome of acute hepatitis B virus infection. Hepatology 2006 1.43
6 Myocardial injury in patients with chronic hepatitis C infection. J Hepatol 2012 1.18
7 Hepatocyte growth factor exerts a proliferative effect on oval cells through the PI3K/AKT signaling pathway. Biochem Biophys Res Commun 2003 1.17
8 Retinoic acid receptor alpha dominant negative form causes steatohepatitis and liver tumors in transgenic mice. Hepatology 2004 1.16
9 Percutaneous sonographically guided radiofrequency ablation with artificial pleural effusion for hepatocellular carcinoma located under the diaphragm. AJR Am J Roentgenol 2004 1.13
10 A multicenter, open-label, dose-ranging study to exploratively evaluate the efficacy, safety, and dose-response of tolvaptan in patients with decompensated liver cirrhosis. J Gastroenterol 2010 1.10
11 Hepatocellular carcinoma with sarcomatous change arising after radiofrequency ablation for well-differentiated hepatocellular carcinoma. Hepatol Res 2003 1.09
12 Nucleotide analogs for patients with HBV-related hepatocellular carcinoma increase the survival rate through improved liver function. Intern Med 2009 1.06
13 Aberrant expression of selenoproteins in the progression of colorectal cancer. Cancer Lett 2007 1.05
14 The impact of visceral fat in nonalcoholic fatty liver disease: cross-sectional and longitudinal studies. J Gastroenterol 2007 1.02
15 Complications of radiofrequency ablation for hepatocellular carcinoma in a multicenter study: An analysis of 16 346 treated nodules in 13 283 patients. Hepatol Res 2012 1.02
16 Serum human telomerase reverse transcriptase messenger RNA as a novel tumor marker for hepatocellular carcinoma. Clin Cancer Res 2005 1.01
17 miR-29b, miR-205 and miR-221 enhance chemosensitivity to gemcitabine in HuH28 human cholangiocarcinoma cells. PLoS One 2013 1.00
18 Effects of Sho-Saiko-to on hepatocarcinogenesis and 8-hydroxy-2'-deoxyguanosine formation. Hepatology 2002 0.99
19 Distribution of hepatitis B virus genotypes among patients with chronic infection in Japan shifting toward an increase of genotype A. J Clin Microbiol 2009 0.98
20 Effect of pancreatic juice cytology and/or endoscopic ultrasound-guided fine-needle aspiration biopsy for pancreatic tumor. J Gastroenterol Hepatol 2014 0.97
21 Soluble c-kit receptor mobilizes hematopoietic stem cells to peripheral blood in mice. Exp Hematol 2004 0.96
22 Diaphragmatic perforation and hernia after hepatic radiofrequency ablation. AJR Am J Roentgenol 2003 0.95
23 Caffeine inhibits the proliferation of liver cancer cells and activates the MEK/ERK/EGFR signalling pathway. Basic Clin Pharmacol Toxicol 2008 0.95
24 Association of functional gene polymorphisms of matrix metalloproteinase (MMP)-1, MMP-3 and MMP-9 with the progression of chronic liver disease. J Gastroenterol Hepatol 2005 0.94
25 No association for Chinese HBV-related hepatocellular carcinoma susceptibility SNP in other East Asian populations. BMC Med Genet 2012 0.94
26 Right diaphragmatic defect in hepatic hydrothorax exposed by contrast-enhanced ultrasonography after radiofrequency ablation. Hepatology 2012 0.93
27 Expression of 8-hydroxy-2'-deoxyguanosine in chronic liver disease and hepatocellular carcinoma. Liver Int 2003 0.91
28 The genotypes of IL-1 beta and MMP-3 are associated with the prognosis of HCV-related hepatocellular carcinoma. Intern Med 2010 0.90
29 The influence on liver parenchymal function and complications of radiofrequency ablation or the combination with transcatheter arterial embolization for hepatocellular carcinoma. Hepatol Res 2004 0.90
30 Assessment of ablative margin by unenhanced magnetic resonance imaging after radiofrequency ablation for hepatocellular carcinoma. Eur J Radiol 2011 0.90
31 Contrast-enhanced sonography with perflubutane revealing active bleeding as a complication of radiofrequency ablation. Hepatology 2012 0.89
32 Apoptosis of liver cancer cells by vitamin K2 and enhancement by MEK inhibition. Int J Oncol 2006 0.89
33 Expression of Fhit, Mlh1, and P53 protein in human gallbladder carcinoma. Cancer Lett 2003 0.88
34 Reduction of hepatocarcinogenesis by ursodeoxycholic acid in rats. Carcinogenesis 2002 0.88
35 Sonographic subcutaneous and visceral fat indices represent the distribution of body fat volume. Abdom Imaging 2006 0.88
36 Gefitinib and the modulation of the signaling pathways downstream of epidermal growth factor receptor in human liver cancer cells. J Gastroenterol 2006 0.87
37 Hepatitis B and C virus infection is a risk factor for the development of cholangiocarcinoma. Intern Med 2012 0.87
38 Rapid identification of bacterial species with bacterial DNA microarray in cirrhotic patients with spontaneous bacterial peritonitis. Intern Med 2009 0.86
39 Primary effusion lymphoma of the left scrotum. Intern Med 2003 0.86
40 Qualitative assessment of tumor vascularity in hepatocellular carcinoma by contrast-enhanced coded ultrasound: comparison with arterial phase of dynamic CT and conventional color/power Doppler ultrasound. Eur Radiol 2003 0.86
41 The growth inhibition of hepatocellular and cholangiocellular carcinoma cells by gemcitabine and the roles of extracellular signal-regulated and checkpoint kinases. Oncol Rep 2008 0.86
42 Prevalence of organic colonic lesions in patients meeting Rome III criteria for diagnosis of IBS: a prospective multi-center study utilizing colonoscopy. J Gastroenterol 2012 0.86
43 Therapeutic effects of angiotensin II type 1 receptor blocker, irbesartan, on non-alcoholic steatohepatitis using FLS-ob/ob male mice. Int J Mol Med 2012 0.86
44 Analyses to clarify rich fractions in hepatic progenitor cells from human umbilical cord blood and cell fusion. Biochem Biophys Res Commun 2004 0.85
45 Expression of transforming growth factor-beta 1 in hepatocellular carcinoma in comparison with the non-tumor tissue. Hepatogastroenterology 2003 0.85
46 Isolated metastases of hepatocellular carcinoma in the right atrium: Case report and review of the literature. Oncol Lett 2013 0.85
47 Schistosomiasis japonica identified by laparoscopic and colonoscopic examination. Dig Endosc 2010 0.84
48 Therapeutic effects of ezetimibe for non-alcoholic steatohepatitis in fatty liver shionogi-ob/ob mice. Hepatol Res 2011 0.83
49 Expression of matrix metalloproiteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in hepatocellular carcinoma tissue, compared with the surrounding non-tumor tissue. Res Commun Mol Pathol Pharmacol 2004 0.83
50 Fhit, Mlh1, P53 and phenotypic expression in the early stage of colorectal neoplasms. Oncol Rep 2008 0.83
51 A noncoding RNA gene on chromosome 10p15.3 may function upstream of hTERT. BMC Mol Biol 2009 0.83
52 Therapeutic effects of the direct renin inhibitor, aliskiren, on non-alcoholic steatohepatitis in fatty liver Shionogi ob/ob male mice. Hepatol Res 2013 0.83
53 The growth inhibition of liver cancer cells by paclitaxel and the involvement of extracellular signal-regulated kinase and apoptosis. Oncol Rep 2007 0.82
54 Differential effects of interferon alpha-2b and beta on the signaling pathways in human liver cancer cells. J Gastroenterol 2005 0.81
55 Spatial and chronological differences in hepatitis B virus genotypes from patients with acute hepatitis B in Japan. Hepatol Res 2006 0.81
56 The association of MMP-1, -3 and -9 genotypes with the prognosis of HCV-related hepatocellular carcinoma patients. Res Commun Mol Pathol Pharmacol 2005 0.80
57 Ablative margin states by magnetic resonance imaging with ferucarbotran in radiofrequency ablation for hepatocellular carcinoma can predict local tumor progression. J Gastroenterol 2013 0.80
58 [Case report; Acute renal failure due to IgG4-related retroperitoneal fibrosis]. Nihon Naika Gakkai Zasshi 2012 0.80
59 Nutritional management contributes to improvement in minimal hepatic encephalopathy and quality of life in patients with liver cirrhosis: A preliminary, prospective, open-label study. Hepatol Res 2012 0.80
60 Fhit, E-cadherin, p53, and activation-induced cytidine deaminase expression in endoscopically resected early stage esophageal squamous neoplasia. J Gastroenterol Hepatol 2012 0.80
61 Clinicopathological and patient characteristics of early gastric neoplasia endoscopically resected with loss of Mlh1 expression. Oncol Lett 2010 0.80
62 Effect of an angiotensin-II type-1 receptor blocker, candesartan on hepatic fibrosis in chronic hepatitis C: a prospective study. Hepatogastroenterology 2009 0.79
63 Fatty liver Shionogi-ob/ob mouse: A new candidate for a non-alcoholic steatohepatitis model. Hepatol Res 2012 0.79
64 Assessment of the ablated area after radiofrequency ablation by contrast-enhanced sonography; comparison with virtual sonography with magnetic navigation. Clin Imaging 2010 0.79
65 Protection by Exogenously Added Coenzyme Q(9) against Free Radical-Induced Injuries in Human Liver Cells. J Clin Biochem Nutr 2010 0.79
66 Cerebral pulsatility index by transcranial Doppler sonography predicts the prognosis of patients with fulminant hepatic failure. Clin Imaging 2010 0.79
67 The effects of the selective mineralocorticoid receptor antagonist eplerenone on hepatic fibrosis induced by bile duct ligation in rat. Int J Mol Med 2010 0.79
68 Sequential analysis of diethylnitrosamine-induced hepatocarcinogenesis in rats. Exp Ther Med 2011 0.78
69 Effect of promoter methylation of the p16 gene on phosphorylation of retinoblastoma gene product and growth of hepatocellular carcinoma cells. Tumour Biol 2005 0.78
70 Expression of AID, P53, and Mlh1 proteins in endoscopically resected differentiated-type early gastric cancer. World J Gastrointest Oncol 2012 0.78
71 Naked gene therapy of hepatocyte growth factor for dextran sulfate sodium-induced colitis in mice. Biochem Biophys Res Commun 2006 0.78
72 Preventive effect of caffeine and curcumin on hepato-carcinogenesis in diethylnitrosamine-induced rats. Int J Oncol 2012 0.78
73 [Evaluation of the surveillance program for hepatocellular carcinoma]. Nihon Shokakibyo Gakkai Zasshi 2012 0.78
74 The therapeutic potential of RNA interference: novel approaches for cancer treatment. Curr Pharm Biotechnol 2012 0.78
75 Endothelin-1 enhances fibrogenic gene expression, but does not promote DNA synthesis or apoptosis in hepatic stellate cells. Comp Hepatol 2006 0.78
76 Usefulness of contrast-enhanced ultrasound with Sonazoid for evaluating liver abscess in comparison with conventional B-mode ultrasound. Hepatol Res 2014 0.78
77 Therapeutic effect of adenoviral-mediated hepatocyte growth factor gene administration on TNBS-induced colitis in mice. Biochem Biophys Res Commun 2005 0.78
78 Assessment of the ablated area after radiofrequency ablation by the spread of bubbles: comparison with virtual sonography with magnetic navigation. Hepatogastroenterology 2011 0.78
79 Mechanisms of anti-proliferative effect of JTE-522, a selective cyclooxygenase-2 inhibitor, on human liver cancer cells. Oncol Rep 2007 0.77
80 Preventive effect of JTE-522, a selective cyclooxygenase-2 inhibitor, on DEN-induced hepatocarcinogenesis in rats. Biomed Pharmacother 2010 0.77
81 Assessment of ablative margin after radiofrequency ablation for hepatocellular carcinoma; comparison between magnetic resonance imaging with ferucarbotran and enhanced CT with iodized oil deposition. Eur J Radiol 2011 0.77
82 Preventive effects of ME3738 on hepatic fibrosis induced by bile duct ligation in rats. Hepatol Res 2008 0.76
83 Preventative and therapeutic effects of perindopril on hepatic fibrosis induced by bile duct ligation in rats. Mol Med Rep 2011 0.76
84 Comparison between different thickness umbrella-shaped expandable radiofrequency electrodes (SuperSlim and CoAccess): Experimental and clinical study. Exp Ther Med 2011 0.76
85 Extracellular matrix metabolism-related gene expression in bile duct-ligated rats. Mol Med Rep 2011 0.76
86 The Effects of Olmesartan and Alfacalcidol on Renoprotection and klotho Gene Expression in 5/6 Nephrectomized Spontaneously Hypertensive Rats. Yonago Acta Med 2011 0.75
87 Expression of oxidative stress-related molecules in circulating leukocytes and urine in patients with chronic viral hepatitis. Liver Int 2006 0.75
88 Association between gene polymorphisms of connective tissue growth factor and the progression of chronic liver disease associated with hepatitis C. Intern Med 2014 0.75
89 [A case of splenic abscess in which percutaneous abscess drainage was an effective]. Nihon Shokakibyo Gakkai Zasshi 2009 0.75
90 [Case of villous tumor of the rectum presenting with severe diarrhea and electrolyte depletion syndrome]. Nihon Shokakibyo Gakkai Zasshi 2009 0.75
91 Assessment of track microbubble flow signals on contrast-enhanced ultrasound with perflubutane following percutaneous liver biopsy. Intern Med 2013 0.75
92 Expression of Fhit, Mlh1, p16INK4A and E-cadherin in early gastric neoplasia: Correlation with histological grade and gastric phenotype. Oncol Rep 2007 0.75
93 The prevalence of atherosclerosis in cirrhotic patients: assessment of two aspects of atherosis and sclerosis. Hepatol Res 2007 0.75
94 Functional gene polymorphisms of interleukin-10 are associated with liver disease progression in Japanese patients with hepatitis C virus infection. Intern Med 2011 0.75
95 [An autopsy case of spontaneous rupture of the liver metastasis from esophageal cancer treated with transcatheter arterial embolization]. Nihon Shokakibyo Gakkai Zasshi 2002 0.75
96 Successful treatment of myelodysplastic syndrome and chronic hepatitis C using combined peginterferon-α-2b and ribavirin therapy. Hepatol Res 2014 0.75
97 [Q & A. A raised lesion of the gastric antrum with a tendency to increase in size]. Nihon Shokakibyo Gakkai Zasshi 2012 0.75
98 [Methylhistidine]. Nihon Rinsho 2004 0.75
99 [Case of autosomal dominant polycystic kidney disease presenting hepatic encephalopathy]. Nihon Jinzo Gakkai Shi 2005 0.75
100 Association of TIMP-1 and TIMP-2 gene polymorphisms with progression of liver fibrosis in patients with type C chronic liver disease. Biochem Genet 2013 0.75
101 [A case of von Recklinghausen disease accompanied with duodenal gastrointestinal stromal tumor and carcinoma in adenoma of the sigmoid colon]. Nihon Shokakibyo Gakkai Zasshi 2002 0.75
102 [Q & A: differential diagnosis of epigastric pain and chronic watery diarrhea]. Nihon Shokakibyo Gakkai Zasshi 2010 0.75
103 [Free amino acids]. Nihon Rinsho 2004 0.75
104 [Community health and medicine for gastrointestinal disease]. Nihon Shokakibyo Gakkai Zasshi 2010 0.75
105 Cowden syndrome complicated with hepatocellular carcinoma possibly originating from non-alcoholic steatohepatitis (NASH). Hepatol Res 2011 0.75
106 Myocardial perfusion defects in patients with chronic hepatitis B infection. J Gastroenterol Hepatol 2014 0.75
107 Hepatocellular carcinoma with sarcomatous change arising after eradication of HCV via interferon therapy. Clin Imaging 2006 0.75
108 [A case of gastrointestinal stromal tumor of the duodenum with increased color flow signals]. Nihon Shokakibyo Gakkai Zasshi 2002 0.75
109 Late complications of self-expandable metallic stent placement for malignant gastric outlet obstruction. Intern Med 2014 0.75
110 [Two cases of primary T cell lymphoma of the small intestine diagnosed by perforated peritonitis]. Nihon Shokakibyo Gakkai Zasshi 2007 0.75
111 Idiopathic intrahepatic arterioportal fistula treated by hepatectomy assisted by balloon-occluded retrograde transvenous obliteration: Report of an elderly case. Hepatol Res 2008 0.75